11-103117775-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001080463.2(DYNC2H1):​c.911A>T​(p.Gln304Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0596 in 1,613,268 control chromosomes in the GnomAD database, including 3,207 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 211 hom., cov: 32)
Exomes 𝑓: 0.061 ( 2996 hom. )

Consequence

DYNC2H1
NM_001080463.2 missense

Scores

1
7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 8.88

Publications

25 publications found
Variant links:
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
DYNC2H1 Gene-Disease associations (from GenCC):
  • asphyxiating thoracic dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
  • Jeune syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Majewski type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Verma-Naumoff type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002502948).
BP6
Variant 11-103117775-A-T is Benign according to our data. Variant chr11-103117775-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 302005.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.062 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYNC2H1NM_001080463.2 linkc.911A>T p.Gln304Leu missense_variant Exon 6 of 90 ENST00000650373.2 NP_001073932.1
DYNC2H1NM_001377.3 linkc.911A>T p.Gln304Leu missense_variant Exon 6 of 89 ENST00000375735.7 NP_001368.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYNC2H1ENST00000650373.2 linkc.911A>T p.Gln304Leu missense_variant Exon 6 of 90 NM_001080463.2 ENSP00000497174.1
DYNC2H1ENST00000375735.7 linkc.911A>T p.Gln304Leu missense_variant Exon 6 of 89 1 NM_001377.3 ENSP00000364887.2

Frequencies

GnomAD3 genomes
AF:
0.0448
AC:
6815
AN:
152128
Hom.:
210
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0127
Gnomad AMI
AF:
0.231
Gnomad AMR
AF:
0.0566
Gnomad ASJ
AF:
0.0649
Gnomad EAS
AF:
0.00750
Gnomad SAS
AF:
0.0532
Gnomad FIN
AF:
0.0210
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0635
Gnomad OTH
AF:
0.0641
GnomAD2 exomes
AF:
0.0493
AC:
12272
AN:
249000
AF XY:
0.0520
show subpopulations
Gnomad AFR exome
AF:
0.0104
Gnomad AMR exome
AF:
0.0440
Gnomad ASJ exome
AF:
0.0718
Gnomad EAS exome
AF:
0.00762
Gnomad FIN exome
AF:
0.0242
Gnomad NFE exome
AF:
0.0644
Gnomad OTH exome
AF:
0.0621
GnomAD4 exome
AF:
0.0611
AC:
89308
AN:
1461022
Hom.:
2996
Cov.:
31
AF XY:
0.0611
AC XY:
44377
AN XY:
726782
show subpopulations
African (AFR)
AF:
0.0104
AC:
349
AN:
33470
American (AMR)
AF:
0.0470
AC:
2101
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0694
AC:
1813
AN:
26112
East Asian (EAS)
AF:
0.00983
AC:
390
AN:
39672
South Asian (SAS)
AF:
0.0523
AC:
4506
AN:
86164
European-Finnish (FIN)
AF:
0.0267
AC:
1425
AN:
53364
Middle Eastern (MID)
AF:
0.0612
AC:
353
AN:
5766
European-Non Finnish (NFE)
AF:
0.0674
AC:
74940
AN:
1111440
Other (OTH)
AF:
0.0569
AC:
3431
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
4199
8398
12596
16795
20994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2808
5616
8424
11232
14040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0448
AC:
6817
AN:
152246
Hom.:
211
Cov.:
32
AF XY:
0.0443
AC XY:
3298
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0127
AC:
527
AN:
41574
American (AMR)
AF:
0.0564
AC:
863
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0649
AC:
225
AN:
3468
East Asian (EAS)
AF:
0.00752
AC:
39
AN:
5186
South Asian (SAS)
AF:
0.0541
AC:
261
AN:
4828
European-Finnish (FIN)
AF:
0.0210
AC:
223
AN:
10612
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0635
AC:
4319
AN:
67972
Other (OTH)
AF:
0.0644
AC:
136
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
326
653
979
1306
1632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0598
Hom.:
233
Bravo
AF:
0.0468
TwinsUK
AF:
0.0588
AC:
218
ALSPAC
AF:
0.0711
AC:
274
ESP6500AA
AF:
0.0134
AC:
51
ESP6500EA
AF:
0.0659
AC:
544
ExAC
AF:
0.0498
AC:
6014
Asia WGS
AF:
0.0200
AC:
69
AN:
3478
EpiCase
AF:
0.0659
EpiControl
AF:
0.0694

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Jeune thoracic dystrophy Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Asphyxiating thoracic dystrophy 3 Benign:2
Nov 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.17
.;T;.;T;.;.
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.85
D;.;D;T;.;T
MetaRNN
Benign
0.0025
T;T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.1
.;M;M;M;M;M
PhyloP100
8.9
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-2.5
.;D;D;.;.;D
REVEL
Benign
0.29
Sift
Benign
0.11
.;T;T;.;.;T
Sift4G
Benign
0.33
.;T;T;.;.;T
Polyphen
0.030, 1.0, 0.087
.;B;D;B;B;B
Vest4
0.56, 0.33, 0.56
MPC
0.063
ClinPred
0.031
T
GERP RS
5.0
Varity_R
0.21
gMVP
0.58
Mutation Taster
=82/18
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12146610; hg19: chr11-102988504; COSMIC: COSV108161704; API